Name
OÜ Narva-Jõesuu Apteek
Registry code
11820456
VAT number
EE101344759
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
14.12.2009 (14)
Financial year
01.01-31.12
Capital
5 010.00 €
Activity
47731 - Dispensing chemist in specialised stores
-
-45 €
-
-
50 004 €
0
Submitted
No tax arrears
-0%
-0%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Omanikukonto: ALEKSEI TAIROV 16.02.1962 (62) | 51% - 2 556.00 EUR | Board member | Direct ownership | Founder |
Aktsiaselts MAGNUM 12371718 | 49% - 2 454.00 EUR | - | - | |
Inna Tairova 10.02.1963 (61) | - | Board member | - | |
Omanikukonto: MARGUS LINNAMÄE 05.01.1964 (60) | - | - | Indirect ownership |
2019 01.07.2020 | 2020 01.07.2021 | 2021 28.06.2022 | 2022 21.06.2023 | 2023 20.06.2024 | |
---|---|---|---|---|---|
Total Revenue | 353 326 € | 66 280 € | 0 € | - | - |
Net profit (loss) for the period | -817 € | -44 351 € | -37 290 € | -6 461 € | -45 € |
Profit Margin | -0% | -67% | - | - | - |
Current Assets | 171 803 € | 99 068 € | 61 836 € | 51 024 € | 50 979 € |
Fixed Assets | 8 489 € | 0 € | - | - | - |
Total Assets | 180 292 € | 99 068 € | 61 836 € | 51 024 € | 50 979 € |
Current Liabilities | 42 141 € | 5 268 € | 5 326 € | 975 € | 975 € |
Non Current Liabilities | - | - | - | - | - |
Total Liabilities | - | - | - | - | - |
Share Capital | - | - | - | - | - |
Equity | 138 151 € | 93 800 € | 56 510 € | 50 049 € | 50 004 € |
Employees | 1 | 1 | 1 | 1 | 0 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | - | - | - | - |
2023 Q4 | - | - | - | - |
2023 Q3 | - | - | - | - |
2023 Q2 | - | - | - | - |
2023 Q1 | - | - | - | 1 |
2022 Q4 | - | - | - | 1 |
2022 Q3 | - | - | - | 1 |
2022 Q2 | - | 1 124.02 € | 1 218.62 € | 1 |
2022 Q1 | - | 3 372.06 € | 3 655.86 € | 1 |
2021 Q4 | - | 3 372.06 € | 3 655.86 € | 1 |
2021 Q3 | - | 3 372.06 € | 3 655.86 € | 1 |
2021 Q2 | - | 3 372.06 € | 3 655.86 € | 1 |
2021 Q1 | - | 3 384.86 € | 3 572.66 € | 1 |
2020 Q4 | - | 3 391.26 € | 3 531.06 € | 1 |
2020 Q3 | - | 3 391.26 € | 3 531.06 € | 1 |
2020 Q2 | 26 145.53 € | 8 309.8 € | 5 837.59 € | 1 |
2020 Q1 | 71 309.8 € | 5 082.45 € | 3 060.62 € | 1 |